Development of a model of focal pneumococcal pneumonia in young rats

Journal of Immune Based Therapies and Vaccines

Volumn 2, Issue , 2004, Pages

  Malley, Richard ^a   Stack, Anne M ^a   Husson, Robert N ^a   Thompson, Claudette M ^b   Fleisher, Gary R ^a   Saladino, Richard A ^a,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; PNEUMOCOCCUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEREMIA; COLONY FORMING UNIT; CONTROLLED STUDY; DEATH; DRUG SCREENING; FEMALE; HISTOPATHOLOGY; INOCULATION; MALE; MORTALITY; NONHUMAN; OUTCOMES RESEARCH; PROPHYLAXIS; RAT; RELIABILITY; SEROTYPE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TISSUE SECTION;

EID: 4243097026     PISSN: 14768518     EISSN: None     Source Type: Journal    
DOI: 10.1186/1476-8518-2-2     Document Type: Article

References (11)

1. WHO meeting on maternal and neonatal pneumococcal immunization. Wkly Epidemiol Rec 1998, 73:187-188.
2. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, Malinoski F, Madore D, Chang I, Kohberger R, Watson W, Austrian R, Edwards K: Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group [In Process Citation]. Pediatr Infect Dis J 2000, 19:187-195.
3. Black SB, Shinefield HR, Hansen J, Elvin L, Laufer D, Malinoski F: Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2001, 20:1105-1107.
4. Hausdorff WP, Bryant J, Paradiso PR, Siber GR: Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I [In Process Citation]. Clin Infect Dis 2000, 30:100-121.
5. Frimodt-Moller N: The mouse peritonitis model: present and future use. J Antimicrob Chemother 1993, 31 Suppl D:55-60.
6. Aaberge IS, Eng J, Lermark G, Lovik M: Virulence of Streptococcus pneumoniae in mice: a standardized method for preparation and frozen storage of the experimental bacterial inoculum. Microb Pathog 1995, 18:141-152.
7. Saladino RA, Stack AM, Fleisher GR, Thompson CM, Briles DE, Kobzik L, Siber GR: Development of a model of low-inoculum Streptococcus pneumoniae intrapulmonary infection in infant rats. Infect Immun 1997, 65:4701-4704.
8. Giebink GS, Berzins IK, Quie PG: Animal models for studying pneumococcal otitis media and pneumococcal vaccine efficacy. Ann Otol Rhinol Laryngol Suppl 1980, 89:339-343.
9. Giebink GS: Otitis media: the chinchilla model. Microb Drug Resist 1999, 5:57-72.
10. Weiser JN, Markiewicz Z, Tuomanen EI, Wani JH: Relationship between phase variation in colony morphology, intrastrain variation in cell wall physiology, and nasopharyngeal colonization by Streptococcus pneumoniae. Infect Immun 1996, 64:2240-2245.
11. Orihuela CJ, Janssen R, Robb CW, Watson DA, Niesel DW: Peritoneal culture alters Streptococcus pneumoniae protein profiles and virulence properties. Infect Immun 2000, 68:6082-6086.